1. Home
  2. CACI vs RVMD Comparison

CACI vs RVMD Comparison

Compare CACI & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CACI International Inc.

CACI

CACI International Inc.

HOLD

Current Price

$581.19

Market Cap

12.9B

Sector

Technology

ML Signal

HOLD

Logo Revolution Medicines Inc.

RVMD

Revolution Medicines Inc.

HOLD

Current Price

$97.52

Market Cap

15.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CACI
RVMD
Founded
1962
2014
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.9B
15.2B
IPO Year
1979
2020

Fundamental Metrics

Financial Performance
Metric
CACI
RVMD
Price
$581.19
$97.52
Analyst Decision
Buy
Strong Buy
Analyst Count
14
17
Target Price
$616.50
$77.47
AVG Volume (30 Days)
254.7K
2.9M
Earning Date
01-21-2026
02-25-2026
Dividend Yield
N/A
N/A
EPS Growth
12.06
N/A
EPS
22.62
N/A
Revenue
$8,858,558,000.00
N/A
Revenue This Year
$10.72
N/A
Revenue Next Year
$6.19
$714.50
P/E Ratio
$24.88
N/A
Revenue Growth
12.61
N/A
52 Week Low
$318.60
$29.17
52 Week High
$632.77
$105.00

Technical Indicators

Market Signals
Indicator
CACI
RVMD
Relative Strength Index (RSI) 58.71 88.59
Support Level $553.49 $76.28
Resistance Level $572.23 $80.48
Average True Range (ATR) 14.86 4.87
MACD 3.59 2.13
Stochastic Oscillator 61.28 91.55

Price Performance

Historical Comparison
CACI
RVMD

About CACI CACI International Inc.

CACI International Inc is an information solutions and services provider, offering information solutions and services to its customers. The company's primary customers are agencies and departments of the U.S. government, which account for the vast majority of the firm's revenue. It provides information solutions and services supporting national security missions and government modernization for intelligence, defense, and federal civilian customers. Some of the services provided by the company are functional software development, data, and business analysis, IT operations support, naval architecture, and life cycle support intelligence among others. The company's operating segments are; Domestic operations and International operations. It derives key revenue from the Domestic segment.

About RVMD Revolution Medicines Inc.

Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.

Share on Social Networks: